Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flora Peyvandi

Showing results (1-10 of 608) with videos related to

Pageof 61
Sort By:
Haematologica|January 30, 2025
More on the pathogenesis of thrombotic thrombocytopenic purpura. Comment on "Acquired thrombotic thrombocytopenic purpura without detectable anti-ADAMTS13 antibodies: a possible underlying autoimmune mechanism" and on "The different faces of thrombotic thrombocytopenic purpura"Flora Peyvandi
Journal of Thrombosis and Haemostasis : JTH|August 2, 2019
Phase 3 study of recombinant von Willebrand factor in patients with severe von Willebrand disease who are undergoing elective surgery: ReplyFlora Peyvandi
Thrombosis Research|February 27, 2013
Epidemiology and treatment of congenital fibrinogen deficiencyFlora Peyvandi
Hematology (Amsterdam, Netherlands)|September 29, 2005
The role of ADAMTS13 in the new pathogenesis of TTPFlora Peyvandi
Blood Transfusion = Trasfusione Del Sangue|February 11, 2009
Rare coagulation disorders: an emerging issueFlora Peyvandi
Seminars in Thrombosis and Hemostasis|November 9, 2005
Carrier detection and prenatal diagnosis of hemophilia in developing countriesFlora Peyvandi
Blood Transfusion = Trasfusione Del Sangue|July 8, 2017
Diagnosis and management of patients with von Willebrand's disease in Italy: an Expert Meeting ReportFlora Peyvandi
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 26, 2012
Willebrand diseaseFlora Peyvandi
Thrombosis Research|January 30, 2010
Results of an international, multicentre pharmacokinetic trial in congenital fibrinogen deficiencyFlora Peyvandi
Blood|December 19, 2018
Treatment of rare factor deficiencies other than hemophiliaMarzia Menegatti, Flora Peyvandi
Pageof 61

Showing results (1-10 of 608) with videos related to

Sort By:
Pageof 61
Haematologica|January 30, 2025
More on the pathogenesis of thrombotic thrombocytopenic purpura. Comment on "Acquired thrombotic thrombocytopenic purpura without detectable anti-ADAMTS13 antibodies: a possible underlying autoimmune mechanism" and on "The different faces of thrombotic thrombocytopenic purpura"Flora Peyvandi
Journal of Thrombosis and Haemostasis : JTH|August 2, 2019
Phase 3 study of recombinant von Willebrand factor in patients with severe von Willebrand disease who are undergoing elective surgery: ReplyFlora Peyvandi
Thrombosis Research|February 27, 2013
Epidemiology and treatment of congenital fibrinogen deficiencyFlora Peyvandi
Hematology (Amsterdam, Netherlands)|September 29, 2005
The role of ADAMTS13 in the new pathogenesis of TTPFlora Peyvandi
Blood Transfusion = Trasfusione Del Sangue|February 11, 2009
Rare coagulation disorders: an emerging issueFlora Peyvandi
Seminars in Thrombosis and Hemostasis|November 9, 2005
Carrier detection and prenatal diagnosis of hemophilia in developing countriesFlora Peyvandi
Blood Transfusion = Trasfusione Del Sangue|July 8, 2017
Diagnosis and management of patients with von Willebrand's disease in Italy: an Expert Meeting ReportFlora Peyvandi
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 26, 2012
Willebrand diseaseFlora Peyvandi
Thrombosis Research|January 30, 2010
Results of an international, multicentre pharmacokinetic trial in congenital fibrinogen deficiencyFlora Peyvandi
Blood|December 19, 2018
Treatment of rare factor deficiencies other than hemophiliaMarzia Menegatti, Flora Peyvandi
Pageof 61